Division of Gastroenterology and Hepatology, Geneva University Hospitals, 4 Rue Gabrielle-Perret-Gentil, Geneva 4 1211, Switzerland.
Division of Gastroenterology and Hepatology, Geneva University Hospitals, 4 Rue Gabrielle-Perret-Gentil, Geneva 4 1211, Switzerland; Division of Clinical Pathology, Geneva University Hospitals, 4 Rue Gabrielle-Perret-Gentil, Geneva 4 1211, Switzerland.
Clin Liver Dis. 2017 Aug;21(3):465-473. doi: 10.1016/j.cld.2017.03.003. Epub 2017 Apr 21.
Hepatitis C virus (HCV) infection is a prevalent condition associated with numerous extrahepatic manifestations. Epidemiologic studies have found that HCV is associated with increased cardiovascular morbidity and mortality, in particular with carotid atherosclerosis, cerebrovascular events, and coronary heart disease. The mechanisms involved encompass a chronic systemic inflammatory state, insulin resistance, and a potential, direct infection of the vascular endothelium. Sustained virologic response with interferon-based regimens is associated with reduced cardiovascular events, although this must be validated with newer direct-acting antivirals. This clear association between HCV and cardiovascular events may have significant economical and public health implications.
丙型肝炎病毒(HCV)感染是一种常见的疾病,与多种肝外表现相关。流行病学研究发现,HCV 与心血管发病率和死亡率的增加有关,特别是与颈动脉粥样硬化、脑血管事件和冠心病有关。涉及的机制包括慢性全身炎症状态、胰岛素抵抗和血管内皮的潜在直接感染。基于干扰素的抗病毒方案的持续病毒学应答与心血管事件的减少相关,尽管这必须通过新型直接作用抗病毒药物来验证。HCV 与心血管事件之间的这种明确关联可能具有重要的经济和公共卫生意义。